kempharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (nces) to treat serious medical conditions through its proprietary and broadly applicable ligand activated therapy (lat) approach.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

CEO

Travis Mickle

kempharm.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

FET's Strong Backlog and Strategy Execution Drive Long-Term Growth

Navan, Inc. (NAVN) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Lakeland Industries, Inc. (LAKE) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

VGTel, Inc. Releases Follow-Up EEG Study Results, Establishing Baseline for Consciousness Research Integrated with UAP and Astronomy Initiatives

Cloudflare's Stablecoin: A Real Catalyst or Short-Term Hype?

Village Gains 16% Year to Date: Should You Buy the Stock?

Here's Why Investors Should Stay Neutral on Lincoln National for Now

ROSEN, A LEADING NATIONAL FIRM, Encourages Gartner, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IT

Franklin BSP Realty Trust, Inc. (FBRT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Vornado Announces Meta's 10-Year Lease at 697 Fifth Avenue, Manhattan

Here's Why You Should Hold OPK Stock in Your Portfolio for Now

ROSEN, A LONGSTANDING INVESTOR RIGHTS FIRM, Encourages Vital Farms, Inc. Investors to Inquire About Securities Class Action Investigation - VITL

PAO Group, Inc. Announces Rescission of Agreement and Departure of CEO James Schramm

Volvo Scraps EX30 U.S. Sales Amid Broader EV Strategy Reset

CAH Posts Strong Cash Flow, Eyes Next Steps in Capital Deployment

3 Dividend ETFs That Can Replace a Pension in 2026

XPeng Q4 Preview: Chinse EV Maker Struggling With Deliveries In 2026, Will Company Silence Critics?

Comtech Telecommunications: Higher-Margin Business Is Paying Off, But Profitability Still Eludes Them

8% Bonds: FSK KKR Beats ECC On Risk

Pelican Acquisition Corporation (NASDAQ: PELI) Announces Successful Approval of its Business Combination with Pelican Holdco, Inc., Greenland Exploration Limited, and March GL Company at the Extraordinary General Meeting of Shareholders held on March 19, 2026

About